Cargando…
SARS-COV-2 virus triggers immune antitumor response in a lymphoma patient()
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Medicina Nuclear e Imagen Molecular. Published by Elsevier España, S.L.U.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125171/ https://www.ncbi.nlm.nih.gov/pubmed/35659732 http://dx.doi.org/10.1016/j.remnie.2022.05.007 |
_version_ | 1784711888521658368 |
---|---|
author | Rudolphi-Solero, T. Rashki, M. Fernández-Fernández, J. Rivas-Navas, D. Ramos-Font, C. Rodríguez-Fernández, A. |
author_facet | Rudolphi-Solero, T. Rashki, M. Fernández-Fernández, J. Rivas-Navas, D. Ramos-Font, C. Rodríguez-Fernández, A. |
author_sort | Rudolphi-Solero, T. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9125171 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Sociedad Española de Medicina Nuclear e Imagen Molecular. Published by Elsevier España, S.L.U. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91251712022-05-23 SARS-COV-2 virus triggers immune antitumor response in a lymphoma patient() Rudolphi-Solero, T. Rashki, M. Fernández-Fernández, J. Rivas-Navas, D. Ramos-Font, C. Rodríguez-Fernández, A. Rev Esp Med Nucl Imagen Mol (Engl Ed) Interesting Images Sociedad Española de Medicina Nuclear e Imagen Molecular. Published by Elsevier España, S.L.U. 2023 2022-05-23 /pmc/articles/PMC9125171/ /pubmed/35659732 http://dx.doi.org/10.1016/j.remnie.2022.05.007 Text en © 2021 Sociedad Española de Medicina Nuclear e Imagen Molecular. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Interesting Images Rudolphi-Solero, T. Rashki, M. Fernández-Fernández, J. Rivas-Navas, D. Ramos-Font, C. Rodríguez-Fernández, A. SARS-COV-2 virus triggers immune antitumor response in a lymphoma patient() |
title | SARS-COV-2 virus triggers immune antitumor response in a lymphoma patient() |
title_full | SARS-COV-2 virus triggers immune antitumor response in a lymphoma patient() |
title_fullStr | SARS-COV-2 virus triggers immune antitumor response in a lymphoma patient() |
title_full_unstemmed | SARS-COV-2 virus triggers immune antitumor response in a lymphoma patient() |
title_short | SARS-COV-2 virus triggers immune antitumor response in a lymphoma patient() |
title_sort | sars-cov-2 virus triggers immune antitumor response in a lymphoma patient() |
topic | Interesting Images |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125171/ https://www.ncbi.nlm.nih.gov/pubmed/35659732 http://dx.doi.org/10.1016/j.remnie.2022.05.007 |
work_keys_str_mv | AT rudolphisolerot sarscov2virustriggersimmuneantitumorresponseinalymphomapatient AT rashkim sarscov2virustriggersimmuneantitumorresponseinalymphomapatient AT fernandezfernandezj sarscov2virustriggersimmuneantitumorresponseinalymphomapatient AT rivasnavasd sarscov2virustriggersimmuneantitumorresponseinalymphomapatient AT ramosfontc sarscov2virustriggersimmuneantitumorresponseinalymphomapatient AT rodriguezfernandeza sarscov2virustriggersimmuneantitumorresponseinalymphomapatient |